Overexpression of E2F1 Promotes Tumor Malignancy And Correlates with TNM Stages in Clear Cell Renal Cell Carcinoma

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ma, Xin ^a   Gao, Yu ^a   Fan, Yang ^a   Ni, Dong ^a   Zhang, Yu ^a   Chen, Weihao ^a   Zhang, Peng ^a   Song, Erlin ^a   Huang, Qingbo ^a   Ai, Qing ^a   Li, Hongzhao ^a   Wang, Baojun ^a   Zheng, Tao ^a   Shi, Taoping ^a   Zhang, Xu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; TRANSCRIPTION FACTOR E2F1;

ADULT; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLONY FORMATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MACROVASCULAR INFILTRATION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; UPREGULATION;

ADULT; CARCINOGENESIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; EXTRACELLULAR MATRIX; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROTEOLYSIS; RETROSPECTIVE STUDIES; S PHASE; UP-REGULATION;

EID: 84883328856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073436     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. PubMed: 21296855.
2. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, et al. (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58: 398-406. PubMed: 20633979.
3. Arjumand W, Sultana S, (2012) Role of VHL gene mutation in human renal cell carcinoma. Tumour Biol 33: 9-16. PubMed: 22125026.
4. Kroeger N, Rampersaud EN, Patard JJ, Klatte T, Birkhäuser FD, et al. (2012) Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol 187: 418-423. PubMed: 22177164.
5. Müller H, Bracken AP, Vernell R, Moroni MC, Christians F, et al. (2001) E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15: 267-285. PubMed: 11159908.
6. Davis JN, Wojno KJ, Daignault S, Hofer MD, Kuefer R, et al. (2006) Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer. Cancer Res 66: 11897-11906. PubMed: 17178887.
7. Worku D, Jouhra F, Jiang GW, Patani N, Newbold RF, et al. (2008) Evidence of a tumour suppressive function of E2F1 gene in human breast cancer. Anticancer Res 28: 2135-2139. PubMed: 18751386.
8. Lee JS, Leem SH, Lee SY, Kim SC, Park ES, et al. (2010) Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol 28: 2660-2667. doi:10.1200/JCO.2009.25.0977. PubMed: 20421545.
9. Iwamoto M, Banerjee D, Menon LG, Jurkiewicz A, Rao PH, et al. (2004) Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification. Cancer Biol Ther 3: 395-399. PubMed: 14726656.
10. Alla V, Engelmann D, Niemetz A, Pahnke J, Schmidt A, et al. (2010) E2F1 in melanoma progression and metastasis. J Natl Cancer Inst 102: 127-133. doi:10.1093/jnci/djp458. PubMed: 20026813.
11. Williams RD, Elliott AY, Stein N, Fraley EE, (1978) In vitro cultivation of human renal cell cancer. II. Characterization of cell lines. In Vitro 14: 779-786. doi:10.1007/BF02617972. PubMed: 721102.
12. Jung M, Ramankulov A, Roigas J, Johannsen M, Ringsdorf M, et al. (2007) In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol Biol 8: 47. doi:10.1186/1471-2199-8-47. PubMed: 17559644.
13. Ai Q, Ma X, Huang Q, Liu S, Shi T, et al. (2012) High-level expression of Notch1 increased the risk of metastasis in T1 stage clear cell renal cell carcinoma. PLOS ONE 7: e35022. doi:10.1371/journal.pone.0035022. PubMed: 22506064.
14. Xie W, Jiang P, Miao L, Zhao Y, Zhimin Z, et al. (2006) Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1. Nucleic Acids Res 34: 2046-2055. PubMed: 16617145.
15. He L, Wang H, Jin H, Guo C, Xie H, et al. (2009) CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett 276: 88-94. doi:10.1016/j.canlet.2008.10.044. PubMed: 19081179.
16. Kim J, Yu W, Kovalski K, Ossowski L, (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94: 353-362. doi:10.1016/S0092-8674(00)81478-6. PubMed: 9708737.
17. Engelmann D, Pützer BM, (2012) The dark side of E2F1: in transit beyond apoptosis. Cancer Res 72: 571-575. PubMed: 22298593.
18. Alonso MM, Fueyo J, Shay JW, Aldape KD, Jiang H, et al. (2005) Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst 97: 1589-1600. PubMed: 16264179.
19. Kwon MJ, Nam ES, Cho SJ, Park HR, Shin HS, et al. (2010) E2F1 expression predicts outcome in Korean women who undergo surgery for breast carcinoma. Ann Surg Oncol 17: 564-571. doi:10.1245/s10434-009-0767-z. PubMed: 19841979.
20. Evangelou K, Kotsinas A, Mariolis-Sapsakos T, Giannopoulos A, Tsantoulis PK, et al. (2008) E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus. J Clin Pathol 61: 601-605. doi:10.1136/jcp.2007.050963. PubMed: 17908803.
21. Johnson DG, Schwarz JK, Cress WD, Nevins JR, (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349-352. doi:10.1038/365349a0. PubMed: 8377827.
22. Montesano R, Orci L, (1985) Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42: 469-477. doi:10.1016/0092-8674(85)90104-7. PubMed: 2411423.
23. Wehrum MJ, Buhimschi IA, Salafia C, Thung S, Bahtiyar MO, et al. (2011) Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol 204411:: e411-e411 e411 PubMed: 21316642.
24. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, et al. (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24: 2375-2385. doi:10.1038/sj.onc.1208429. PubMed: 15674322.
25. Myong NH, (2012) Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression. Korean J Pathol 46: 341-348. PubMed: 23110026.
26. Johnson JL, Pillai S, Pernazza D, Sebti SM, Lawrence NJ, et al. (2012) Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease. Cancer Res 72: 516-526. doi:10.1158/1538-7445.AM2012-516. PubMed: 22086850.
27. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356: 125-134. doi:10.1056/NEJMoa060655. PubMed: 17215530.